Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa F Boyd

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Communications Biology|February 2, 2026
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunityJiansheng Jiang, Abir K Panda, Kannan Natarajan, et al.
Frontiers in Immunology|February 26, 2021
Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated PeptidesMontserrat Puig, Suryatheja Ananthula, Ramesh Venna, et al.
Cancer Immunology Research|October 1, 2025
Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor ImmunityAbir K Panda, Kannan Natarajan, Surajit Sinha, et al.
Cell Reports|October 27, 2022
Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variantsZhaochun Chen, Peng Zhang, Yumiko Matsuoka, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variantsZhaochun Chen, Peng Zhang, Yumiko Matsuoka, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Communications Biology|February 2, 2026
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunityJiansheng Jiang, Abir K Panda, Kannan Natarajan, et al.
Frontiers in Immunology|February 26, 2021
Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated PeptidesMontserrat Puig, Suryatheja Ananthula, Ramesh Venna, et al.
Cancer Immunology Research|October 1, 2025
Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor ImmunityAbir K Panda, Kannan Natarajan, Surajit Sinha, et al.
Cell Reports|October 27, 2022
Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variantsZhaochun Chen, Peng Zhang, Yumiko Matsuoka, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variantsZhaochun Chen, Peng Zhang, Yumiko Matsuoka, et al.
Pageof 4